CLOSE

Specials

  • March
  • BioTech Startups
  • Genomics Europe
  • Bioanalytical Services Europe
  • Sustainable Technologies
  • BioTech Startup APAC
  • Life Science Packaging
  • Europe
  • APAC
  • Bioanalytical Services APAC
  • Life Science Compliance
  • Life Science Analytics
  • Bioanalytical Services
  • September
  • June
  • Contract Research Organization

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
APAC
EUROPE
  • Home
  • News
  • Contributors
  • Magazine
  • Conferences
  • Newsletter
  • About

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Drug Development: The Role of Analytical and Bioanalytical Sciences

Drug Development: The Role of...

An Insight into Pharmaceutical Analytical Testing Services' Market

An Insight into Pharmaceutical...

Why is Drug Discovery and Essential Practice

Why is Drug Discovery and Essential...

PCR Biosystems Launches a Range of IsoFast Bst Polymerase Reagents

PCR Biosystems Launches a Range of...

Navigo Proteins and Eleva Announce Successful Development of an Affinity Chromatography Resin

Navigo Proteins and Eleva Announce...

What are Regulatory Submissions in Bioanalytics

What are Regulatory Submissions in...

Using Technology to Simplify the Drug Development Journey

Using Technology to Simplify the Drug...

Recent Trends and Developments in Pharmaceutical Industry

Recent Trends and Developments in...

Drug Development: The Role of Analytical and Bioanalytical Sciences

Drug Development: The Role of...

An Insight into Pharmaceutical Analytical Testing Services' Market

An Insight into Pharmaceutical...

Why is Drug Discovery and Essential Practice

Why is Drug Discovery and Essential...

PCR Biosystems Launches a Range of IsoFast Bst Polymerase Reagents

PCR Biosystems Launches a Range of...

Navigo Proteins and Eleva Announce Successful Development of an Affinity Chromatography Resin

Navigo Proteins and Eleva Announce...

What are Regulatory Submissions in Bioanalytics

What are Regulatory Submissions in...

Using Technology to Simplify the Drug Development Journey

Using Technology to Simplify the Drug...

Recent Trends and Developments in Pharmaceutical Industry

Recent Trends and Developments in...

Bioanalytical Challenges of Antibody Drug Conjugates

By Life Sciences Review | Thursday, March 18, 2021
Tweet

The bioanalysis of antibody-drug conjugates (ADCs) is essential for understanding pharmaceutical drug safety and efficiency. 


FREMONT, CA: Bioanalysis of antibody-drug conjugates (ADCs) is essential for evaluating the safety and efficacy of this rapidly increasing class of pharmaceuticals. Here are some of the reasons that make ADC bioanalysis so complicated. ADCs are made up of cytotoxic small molecule drugs that have been chemically linked to an antibody. The antibody recognizes a tumor-associated antigen that is only expressed in a limited number of normal cells.


Cleavable chemical linkers are developed to remain stable in the circulation and release the cytotoxic drug (also known as the "payload") when some aspects inside the target cell are triggered. A refined pH range, high glutathione concentrations, or proteolytic cleavage are examples of "releasing" triggers. The resulting free drug will destroy the target cell directly and then leave the cell, causing "bystander killing" of nearby cells.


Non-cleavable linkers, on the other hand, lack an apparent proteolytic cleavage site, allowing the cytotoxic payload to remain inside the cell. ADCs with non-cleavable linkers activate the cytotoxic payload rather than the linker when the antibody is degraded. 


ADCs are made up of several different components. 


In some cases, the cytotoxic drug may efflux from the cell and be metabolized into smaller segments with other anticancer activity to the parent drug. In general, intact ADCs, free drug molecules, conjugated antibody, and complete antibody are all measured in ADC bioanalysis. This diverse group of organisms poses unique bioanalytical challenges, necessitating identifying techniques appropriate for various stages of research and development.


ADC components are heterogenous


One of the critical causes of variability is the number of drugs attached to every antibody. The drug-to-antibody ratio (DAR), described as the average number of drugs conjugated to each antibody (usually between 0 and 8), influences stability, antigen binding, and, eventually, ADC potency. A lower DAR can minimize ADC potency, whereas a high drug loading can boost clearance, increase the risk of accumulation, and cause the toxic payload to be released prematurely into the circulation.


The conjugation area at which the payload is conjugated to the antibody is another source of heterogeneity. In the meantime, efforts are being made to generate more homogeneous ADCs by monitoring the site and number of drugs conjugated to the antibody, but analytical procedures must account for this variability.


Weekly Brief

loading
Towards a New World Order
> <
  • Life Science Compliance 2021

    Top Vendors

    Current Issue
  • Other 2021

    Top Vendors

    Current Issue

Read Also

Genome Sequencing Technology Becoming More Efficient

Genome Sequencing Technology Becoming More Efficient

Contract Research Organization: Top Benefits

Contract Research Organization: Top Benefits

Genomics: How Can Employing AI Enhance Healthcare?

Genomics: How Can Employing AI Enhance Healthcare?

The Potential of Strategic Partnering with CROs

The Potential of Strategic Partnering with CROs
Advantages of Using Glass Pharmaceutical Packaging

Advantages of Using Glass Pharmaceutical Packaging

How Cloud-Based LIMS Helps CROs

How Cloud-Based LIMS Helps CROs

Pharma and Biotech are Looking to Cloud and AI to Expediate Drug Discovery

Pharma and Biotech are Looking to Cloud and AI to Expediate Drug Discovery

What You Should Know About Biotechnology

What You Should Know About Biotechnology
Loading...

Copyright © 2021 Life Science Review . All rights reserved. |  Subscribe follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/bioanalytical-challenges-of-antibody-drug-conjugates-nwid-293.html